Where studies have been carried out, most are in animals or cells
Timestamps 0:00 A 43-year-old man is getting weaker, not stronger 2:09 Taking the history: Medications, lifestyle, and red flags 12:53 The labs come back: CK at 18,979 16:05 Metabolic syndrome and the modern treatment approach 23:15 Rhabdomyolysis: What it is and why its dangerous 29:50 Final diagnosis and what went wrong with the medications 37:15 2026 ACC lipid guidelines: What changed 40:32 Three mechanisms: How statins affect muscle 47:02 The nocebo effect and the SAMSON trial 54:17 Do statins impair training
GLP-1 Benefits: Sustainable fat loss (especially belly + visceral fat) Balanced blood sugar and improved insulin sensitivity Reduced cravings and emotional eating Enhanced focus and stable daily energy HGH-Support Peptides: Repair, Recovery & Radiance These peptides help your body naturally increase its own growth-hormone pulses no synthetic shortcuts, just a biological reboot
For weight management, NICE has appraised several licensed medicines that are available through NHS pathways or regulated private clinics: Semaglutide (Wegovy) NICE Technology Appraisal TA875 recommends semaglutide as an option for managing overweight and obesity in adults with a BMI of 35 kg/m or more (or 3034.9 kg/m in certain circumstances) alongside at least one weight-related comorbidity, when used within a specialist weight management service
Impact of dementia caregiving: Risks, strains, and growth